Just as Fisher DT et al. reviewed the two faces of IL-6 in the tumor microenvironment, while IL-6 signaling is generally considered as a key driver of malignancy, accumulating evidence establishes IL-6 is a key player in the mobilization of anti-tumor T cell responses54. Here, IL6 is linked to neoplasm.